Evaluation of antihyperlipidemic activity of leaves of Portulaca oleracea Linn against dexamethasone induced hyperlipidemia in rats

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue SUPPL. 4, 2012, Pages 279-283

  Pragda, Sankara Sastry ^a   Kuppast, I J ^b   Mankani, K L ^b   Ramesh, L ^b  

^a NATIONAL COLLEGE OF PHARMACY   (India)

^b VINAYAKA MISSION S RESEARCH FOUNDATION DEEMED TO BE UNIVERSITY   (India)

Author keywords

Dexamethasone; Diabetes mellitus; Hyperlipidemia; Portulaca oleracea linn

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; DEXAMETHASONE; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PETROLEUM ETHER; PHOSPHOLIPID; PORTULACA OLERACEA EXTRACT; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HYPERLIPIDEMIA; MALE; MEDICINAL PLANT; NONHUMAN; PLANT LEAF; PORTULACACEAE; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84866330309     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ghatak A. And Asthana O.P. Recent trends in hyperlipoproteinemias and its Pharmacotherapy. Indian.J. Pharm 1995;27:14-29
2. Moss J.N. and Dajani E, Antihyperlipidemic agents, in screening methods of toxicology, Vol:II. Academic Press; Newyork; R.A. Turner and P. Hebborn; 1971.p.121.
3. Anon, Drug Index, Pass Publication Pvt. Ltd., New Delhi; 1999. p.482.
4. E.C. Wilson: screening plants for new medicines, Biodiversity, National Academy Press, Washington D.C. p.51.
5. Lim YY, Quah EPL. Antioxidant properties of different cultivars of Portulaca oleracea. Food Chem 2007; 103:734-740.
6. Chan K, Islam MW, Kamil M, Radhakrishnan R, Zakaria MNM, Habibullah M, et al. The analgesic and anti-inflammatory effects of Portulaca oleracea L. subsp. sativa (Haw.) Celak. J Ethnopharmacol 2000; 73:445-451.
7. Abas F, Lajis NH, Israf DA, Khozirah S, Kalsom YU. Antioxidant and nitric oxide inhibition activities of selected Malay traditional vegetables. Food Chem 2006; 95:566-573.
8. Yen GC, Chen HY, Peng HH. Evaluation of the cytotoxicity, mutagenicity and antimutagenicity of emerging edible plants. Food Chem Toxicol 2001; 39:1045-1053.
9. Zimmerman M. Ethical guidlines for investigation of experimental pain in conscious animals, pain 1983. 16:109-110.
10. Courtesy: http://facnlty.vassar.edn/lowry/ank3.html
11. Sofowora A. Screening plants for bioactive agents, In: Medicinal plant and Traditional Medicine in Africa. 2nd ed. Ibadan:Spectrum Books Ltd.; 1993. p. 289.
12. Evans WC. An overview of drugs having antihepatotoxic and oral hypoglycaemic activities. In: Trease and Evans, Pharmacognosy, 14th ed. U.K.: Sanders Company Ltd.; 1996. p.119-59.
13. Haughton PJ, Raman A. Laboratory handbook for the fractionation of natural extracts. 1st ed. USA: Clapman and Hall; 1998. p. 22-52.
14. Courtesy:http://cn.wikipedia.org/wiki/dexamethasone.
15. Eric D. Brader, Pevig C. Lee, and Hershol Raff. Dexamethasone treatment in the newborn rat: fatty acid profiling of lung, brain and serum lipids. j. Appl. Physiol. 2005; 98:981-990.
16. Mahendran and C. S Shyamala Devi, Effect of Garcinia Cambogia Extract on lipids and lipoprotein composition in dexamethasone administered rats, Indian Journal of Physio and Pharmacol 2001; 45(3) 345-350.
17. rd Edition, Vallabh Prakashan, 172-179.
18. Courtesy: http://faciilty.vassar.edii/lowry/ank3.html.
19. N.V. Bhagavan, Medical Biochemistry, Jones and Barlett publisher, Boston, 1992;420.
20. Bopanna K N, Bhagyalakshmi N, Rathod S P, Balaraman R& Kannan J, Cell culture derived Hemidesmus indicus in the prevention of hypercholesterolemia in normal and hyperlipidemic rats, Indian J Pharmacol,1997;29:105.